Article Listing - UPDATE: Sanofi-Aventis reports forecast-beating earnings, 1st-qtr sales up 11.9%

NOVO NORDISK TO INVEST IN SPAIN

20 April 1992

The Danish drug manufacturer Novo Nordisk is looking for ways to invest in Spain through its Spanish subsidiary, Novo Nordisk...

1991 A BAD YEAR FOR SOLVAY

20 April 1992

Consolidated net profits at the Belgian chemicals company Solvay fell 22% in 1991 to 12.4 billion Belgian francs ($367.6 million)...

HALCION BAN INCREASES PATIENT RISKS

20 April 1992

Specialists speaking at a symposium organized by the UK Robens Institute of Health and Safety held in London, have deplored...

USA: MINNESOTA HEALTHRIGHT PLAN

20 April 1992

Last week, the state of Minnesota was expected to adopt its massive and controversial HealthRight plan, making it the first...

TRIAL COULD BOOST VIDEX ACCEPTANCE

20 April 1992

Results of a clinical study involving Bristol-Myers Squibb's antiviral Videx (didanosine) as a treatment for patients with AIDS suggest that...

ICI HONORED FOR DIPRIVAN ADVANCE

20 April 1992

The UK's ICI Pharmaceuticals has been granted the 1992 Queen's Award for Technological Achieve-ment for the development of the injectable...

ICI AMERICAS IN DELAWARE

20 April 1992

The pharmaceutical group of ICI Americas is investing $24.7 million in an expansion project at its Newark, Delaware site. Construction...

FIRST QTR RESULTS FROM DEPRENYL

20 April 1992

Canadian pharmaceutical company Deprenyl Research Ltd achieved revenues of C$2.8 million ($2.3 million) in the first quarter of 1992, an...

ONO RESEARCHING NOVEL ANTIVIRAL

20 April 1992

Scientists at Ono Pharmaceutical and the Tokushima Bunri University in Japan have identified a potential antiviral agent from eucalyptus leaves,...

CURATEK FILES NDA FOR METROGEL-V

20 April 1992

Illinois, USA-based Curatek Pharma-ceuticals has submitted a New Drug Application to the Food and Drug Administration for a topical formulation...

Showing 94451-94460 of 95558 articles

Go to beginningPreviousNextGo to end